Listing 1 - 6 of 6 |
Sort by
|
Choose an application
Animal psychology and neurophysiology --- Neurons --- Nerve Regeneration --- Nerve Growth Factors --- growth and development --- Nerve Growth Factors. --- Nerve Regeneration. --- Neurons. --- Nerve Cells --- Cell, Nerve --- Cells, Nerve --- Nerve Cell --- Neuron --- Nerve Regenerations --- Regeneration, Nerve --- Regenerations, Nerve --- Nerve Transfer --- Growth-Associated Proteins, Neuronal --- Neuronal Growth-Associated Proteins --- Neuronotrophic Factors --- Neurotrophic Protein --- Neurotrophic Proteins --- Proteins, Neuronal Growth-Associated --- Neurite Outgrowth Factors --- Neurotrophic Factors --- Neurotrophins --- Factors, Nerve Growth --- Factors, Neurite Outgrowth --- Factors, Neuronotrophic --- Factors, Neurotrophic --- Growth Associated Proteins, Neuronal --- Neuronal Growth Associated Proteins --- Outgrowth Factors, Neurite --- Neurites --- NERVE GROWTH FACTORS --- NERVE REGENERATION --- NEURONS --- Growth and development --- Nerve growth factors --- Nerve regeneration --- Neurons - growth and development - congresses --- Nerve Regeneration - congresses --- Nerve Growth Factors - congresses
Choose an application
Fibroblast growth factor (FGF) signal transmission has an essential function in embryonic development and tissue repair, and is dysregulated in the vast majority of malignancies studied. The FGF signaling in the tumor cells is usually increased by autocrine and paracrine mechanisms and gives them a high growth potential, resistance to apoptosis, neoangiogenesis and metastasis, all essential parameters relevant for tumor progression. This makes FGFs, and their tyrosine kinase receptors FGFRs, valuable targets for therapeutic interventions. This book is a collection of 15 recent articles—both original work and reviews—that summarize the current research state effectively. The content covers FGF signaling aspects in gastric, skin, liver, esophageal cancer, melanoma, mesothelioma and glioblastoma, including one article that addresses the role of FGF in the tumor-microenvironment cross-talk. Several reports describe the development of compounds targeting FGFRs, their structure and interaction with the receptor molecules, and their effectivity in preclinical and clinical testing. In summary, the papers demonstrate the complexity of the topic, with various FGF ligands and receptors involved and the need for further research. They also present results that fuel hope that targeting cancer with dysfunctional FGF signaling can become a realistic treatment option.
Medicine --- FGFR4 --- FGF19 --- gene regulation --- cancer signaling --- anticancer --- FRS2 --- FGFR --- NVP-BGJ398 --- LY2874455 --- sarcoma --- cancer-associated fibroblasts --- GPER --- breast cancer --- estrogen --- FGFR1 --- FGF2 --- optogenetics --- ERK --- AKT --- receptor kinase --- neurite outgrowth --- HEK293 --- PC12 --- fibroblast growth factor receptors --- signaling --- receptor cross-talk --- coreceptor --- membrane proteins --- FGFR2 --- ERK1/2 --- phosphorylation --- serine --- negative feedback loop --- cancer --- prognosis --- HCC --- inhibitors --- FGF --- fibroblast growth factor --- autocrine signaling --- skin --- melanoma --- squamous and basal cell carcinoma --- seborrheic keratosis --- targeted therapy --- resistance --- structure --- kinase inhibitor --- gastric cancer --- monoclonal antibody --- small molecule --- FGFR2c --- autophagy --- keratinocyte --- MTOR --- JNK1 --- review --- malignant glioma --- brain cancer --- astrocytoma --- Sprouty proteins --- FGF-mediated signaling --- tumor suppressor --- tumor promoter --- malignant pleural mesothelioma --- overall survival --- immunohistochemistry --- infigratinib sensitivity --- FGF8 --- FGF18 --- adenocarcinoma of the esophagogastric junction --- neoadjuvant therapy --- n/a
Choose an application
Recently, stem cells have been drawing increasing interest in basic and translational research that aims to understand stem cell biology and generate new therapies for various disorders. Many stem cells can be cultured in 2D relatively easily using tissue culture plastic. However, many of these cultures do not represent the natural conditions of stem cells in the body. In the body, microenvironments include numerous supporting cells and molecules. Therefore, researchers and clinicians have sought ideal stem cell preparations for basic research and clinical applications, which may be attainable through 3D culture of stem cells. The 3D cultures mimic the conditions of the natural environment of stem cells better, as cells in 3D cultures exhibit many unique and desirable characteristics that could be beneficial for therapeutic interventions. 3D stem cell cultures may employ supporting structures, such as various matrices or scaffolds, in addition to stem cells, to support complex structures. This book brings together recent research on 3D cultures of various stem cells to increase the basic understanding of stem cell culture techniques and also to highlight stem cell preparations for possible novel therapeutic applications.
Research & information: general --- Biology, life sciences --- hematopoiesis --- hematopoietic stem cells --- stem cell culture --- 2D culture --- 3D culture --- embryonic stem cells --- three-dimensional --- self-assembling scaffold --- pluripotency --- culture conditions --- expansion --- growth --- niche --- human cortical progenitors --- silicon pillars --- cell growth --- hiPSC-derived neural progenitors --- cerebral cortex --- carcinogen --- protein phosphatase 2A (PP2A) --- intestinal tumor --- intestinal organoid --- Lgr5+ crypt stem cell --- mouse embryonic stem cell --- differentiation protocol --- ureteric bud progenitor cells --- 3D kidney organoids --- intestinal organoids --- canine intestine --- differentiation --- organoid culture --- induced pluripotent stem cells --- neurospheres --- neurite outgrowth --- neurotoxicity --- hBM-MSCs --- cytokines --- tenogenic markers --- cyclic strain --- 3D microenvironment --- PLGA carriers --- bioreactor --- cardiac microtissues --- iPSC-derived cardiomyocytes --- cardiac fibroblasts --- cardiac fibrosis --- cardiac rhythm --- TGF-β signalling --- drug screening --- in vitro model --- stem cell --- 3D --- culture condition --- regenerative medicine --- scaffold --- organoid --- adipose tissue-derived mesenchymal stem cells --- stromal vascular fraction --- platelet rich plasma --- platelet concentrates --- veterinary regenerative medicine
Choose an application
Fibroblast growth factor (FGF) signal transmission has an essential function in embryonic development and tissue repair, and is dysregulated in the vast majority of malignancies studied. The FGF signaling in the tumor cells is usually increased by autocrine and paracrine mechanisms and gives them a high growth potential, resistance to apoptosis, neoangiogenesis and metastasis, all essential parameters relevant for tumor progression. This makes FGFs, and their tyrosine kinase receptors FGFRs, valuable targets for therapeutic interventions. This book is a collection of 15 recent articles—both original work and reviews—that summarize the current research state effectively. The content covers FGF signaling aspects in gastric, skin, liver, esophageal cancer, melanoma, mesothelioma and glioblastoma, including one article that addresses the role of FGF in the tumor-microenvironment cross-talk. Several reports describe the development of compounds targeting FGFRs, their structure and interaction with the receptor molecules, and their effectivity in preclinical and clinical testing. In summary, the papers demonstrate the complexity of the topic, with various FGF ligands and receptors involved and the need for further research. They also present results that fuel hope that targeting cancer with dysfunctional FGF signaling can become a realistic treatment option.
Medicine --- FGFR4 --- FGF19 --- gene regulation --- cancer signaling --- anticancer --- FRS2 --- FGFR --- NVP-BGJ398 --- LY2874455 --- sarcoma --- cancer-associated fibroblasts --- GPER --- breast cancer --- estrogen --- FGFR1 --- FGF2 --- optogenetics --- ERK --- AKT --- receptor kinase --- neurite outgrowth --- HEK293 --- PC12 --- fibroblast growth factor receptors --- signaling --- receptor cross-talk --- coreceptor --- membrane proteins --- FGFR2 --- ERK1/2 --- phosphorylation --- serine --- negative feedback loop --- cancer --- prognosis --- HCC --- inhibitors --- FGF --- fibroblast growth factor --- autocrine signaling --- skin --- melanoma --- squamous and basal cell carcinoma --- seborrheic keratosis --- targeted therapy --- resistance --- structure --- kinase inhibitor --- gastric cancer --- monoclonal antibody --- small molecule --- FGFR2c --- autophagy --- keratinocyte --- MTOR --- JNK1 --- review --- malignant glioma --- brain cancer --- astrocytoma --- Sprouty proteins --- FGF-mediated signaling --- tumor suppressor --- tumor promoter --- malignant pleural mesothelioma --- overall survival --- immunohistochemistry --- infigratinib sensitivity --- FGF8 --- FGF18 --- adenocarcinoma of the esophagogastric junction --- neoadjuvant therapy --- n/a
Choose an application
Recently, stem cells have been drawing increasing interest in basic and translational research that aims to understand stem cell biology and generate new therapies for various disorders. Many stem cells can be cultured in 2D relatively easily using tissue culture plastic. However, many of these cultures do not represent the natural conditions of stem cells in the body. In the body, microenvironments include numerous supporting cells and molecules. Therefore, researchers and clinicians have sought ideal stem cell preparations for basic research and clinical applications, which may be attainable through 3D culture of stem cells. The 3D cultures mimic the conditions of the natural environment of stem cells better, as cells in 3D cultures exhibit many unique and desirable characteristics that could be beneficial for therapeutic interventions. 3D stem cell cultures may employ supporting structures, such as various matrices or scaffolds, in addition to stem cells, to support complex structures. This book brings together recent research on 3D cultures of various stem cells to increase the basic understanding of stem cell culture techniques and also to highlight stem cell preparations for possible novel therapeutic applications.
hematopoiesis --- hematopoietic stem cells --- stem cell culture --- 2D culture --- 3D culture --- embryonic stem cells --- three-dimensional --- self-assembling scaffold --- pluripotency --- culture conditions --- expansion --- growth --- niche --- human cortical progenitors --- silicon pillars --- cell growth --- hiPSC-derived neural progenitors --- cerebral cortex --- carcinogen --- protein phosphatase 2A (PP2A) --- intestinal tumor --- intestinal organoid --- Lgr5+ crypt stem cell --- mouse embryonic stem cell --- differentiation protocol --- ureteric bud progenitor cells --- 3D kidney organoids --- intestinal organoids --- canine intestine --- differentiation --- organoid culture --- induced pluripotent stem cells --- neurospheres --- neurite outgrowth --- neurotoxicity --- hBM-MSCs --- cytokines --- tenogenic markers --- cyclic strain --- 3D microenvironment --- PLGA carriers --- bioreactor --- cardiac microtissues --- iPSC-derived cardiomyocytes --- cardiac fibroblasts --- cardiac fibrosis --- cardiac rhythm --- TGF-β signalling --- drug screening --- in vitro model --- stem cell --- 3D --- culture condition --- regenerative medicine --- scaffold --- organoid --- adipose tissue-derived mesenchymal stem cells --- stromal vascular fraction --- platelet rich plasma --- platelet concentrates --- veterinary regenerative medicine
Choose an application
Fibroblast growth factor (FGF) signal transmission has an essential function in embryonic development and tissue repair, and is dysregulated in the vast majority of malignancies studied. The FGF signaling in the tumor cells is usually increased by autocrine and paracrine mechanisms and gives them a high growth potential, resistance to apoptosis, neoangiogenesis and metastasis, all essential parameters relevant for tumor progression. This makes FGFs, and their tyrosine kinase receptors FGFRs, valuable targets for therapeutic interventions. This book is a collection of 15 recent articles—both original work and reviews—that summarize the current research state effectively. The content covers FGF signaling aspects in gastric, skin, liver, esophageal cancer, melanoma, mesothelioma and glioblastoma, including one article that addresses the role of FGF in the tumor-microenvironment cross-talk. Several reports describe the development of compounds targeting FGFRs, their structure and interaction with the receptor molecules, and their effectivity in preclinical and clinical testing. In summary, the papers demonstrate the complexity of the topic, with various FGF ligands and receptors involved and the need for further research. They also present results that fuel hope that targeting cancer with dysfunctional FGF signaling can become a realistic treatment option.
FGFR4 --- FGF19 --- gene regulation --- cancer signaling --- anticancer --- FRS2 --- FGFR --- NVP-BGJ398 --- LY2874455 --- sarcoma --- cancer-associated fibroblasts --- GPER --- breast cancer --- estrogen --- FGFR1 --- FGF2 --- optogenetics --- ERK --- AKT --- receptor kinase --- neurite outgrowth --- HEK293 --- PC12 --- fibroblast growth factor receptors --- signaling --- receptor cross-talk --- coreceptor --- membrane proteins --- FGFR2 --- ERK1/2 --- phosphorylation --- serine --- negative feedback loop --- cancer --- prognosis --- HCC --- inhibitors --- FGF --- fibroblast growth factor --- autocrine signaling --- skin --- melanoma --- squamous and basal cell carcinoma --- seborrheic keratosis --- targeted therapy --- resistance --- structure --- kinase inhibitor --- gastric cancer --- monoclonal antibody --- small molecule --- FGFR2c --- autophagy --- keratinocyte --- MTOR --- JNK1 --- review --- malignant glioma --- brain cancer --- astrocytoma --- Sprouty proteins --- FGF-mediated signaling --- tumor suppressor --- tumor promoter --- malignant pleural mesothelioma --- overall survival --- immunohistochemistry --- infigratinib sensitivity --- FGF8 --- FGF18 --- adenocarcinoma of the esophagogastric junction --- neoadjuvant therapy --- n/a
Listing 1 - 6 of 6 |
Sort by
|